Downregulation of p53 by phosphatase of regenerating liver 3 is mediated by MDM2 and PIRH2
Authors:
- Dong Min KimDKDong Min Kim
- Young-Shin HeoYHYoung-Shin Heo
- Ho Min KimHKHo Min Kim
- Il-Chul KimIKIl-Chul Kim
- Ook-Joon YooOYOok-Joon Yoo
- 1 January 2010
- journal article
- Published by Elsevier in Life Sciences
- Vol. 86 (1-2) , 66-72
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- New p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53Oncogene, 2008
- PRL-1 Tyrosine Phosphatase Regulates c-Src Levels, Adherence, and Invasion in Human Lung Cancer CellsCancer Research, 2007
- Targeted Therapy of DNA Tumor Virus-Associated Cancers Using Virus-Activated Transcription FactorsMolecular Therapy, 2006
- Alterations in Vascular Gene Expression in Invasive Breast CarcinomaCancer Research, 2004
- Protein Tyrosine Phosphatases in the Human GenomeCell, 2004
- The Tyrosine Phosphatase PRL-1 Localizes to the Endoplasmic Reticulum and the Mitotic Spindle and Is Required for Normal MitosisJournal of Biological Chemistry, 2002
- Interaction of Farnesylated PRL-2, a Protein-tyrosine Phosphatase, with the β-Subunit of Geranylgeranyltransferase IIJournal of Biological Chemistry, 2001
- Prenylation-dependent Association of Protein-tyrosine Phosphatases PRL-1, -2, and -3 with the Plasma Membrane and the Early EndosomeJournal of Biological Chemistry, 2000
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- p53-mediated transcription induces resistance of DNA to UV inactivationOncogene, 1998